Overview

Cytisine Versus Varenicline for Smoking Cessation

Status:
Completed

Trial end date:
2019-10-10

Target enrollment:

Participant gender:

Summary

To evaluate the effectiveness, safety, and cost-effectiveness of cytisine plus behavioural support compared to varenicline plus behavioural support for smoking cessation, in indigenous Māori (or family of Māori) who smoke and are motivated to quit.

Phase:

Phase 3

Details

Lead Sponsor:

University of Auckland, New Zealand

Collaborators:

Brunel University
Lakes District Health Board

Treatments:

Varenicline